Skip to main content

Published locations for HER2 status differed between primary tumor and CTCs in 18.8% of women with MBC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. HER2 status differed between primary tumor and CTCs in 18.8% of women with MBC

User login

  • Reset your password
  • /content/her2-status-differed-between-primary-tumor-and-ctcs-188-women-mbc
  • /obgynnews/article/148279/breast-cancer/her2-status-differed-between-primary-tumor-and-ctcs-188-women
  • /oncologypractice/article/148279/breast-cancer/her2-status-differed-between-primary-tumor-and-ctcs
  • /obgyn/article/148279/breast-cancer/her2-status-differed-between-primary-tumor-and-ctcs-188-women-mbc
  • /hematology-oncology/article/148279/breast-cancer/her2-status-differed-between-primary-tumor-and-ctcs
  • /advanced-and-metastatic-breast-cancer/article/148279/breast-cancer/her2-status-differed-between
  • /breast-cancer-icymi/article/148279/breast-cancer/her2-status-differed-between-primary-tumor-and-ctcs